Janus Henderson Investors

Asset manager
London, United KingdomFounded 2017$181M AUMwww.janushenderson.com

Global asset manager providing sophisticated investment solutions and research-driven insights to financial professionals, individual investors, and institutional clients.

Strategy

Geographies
London, United Kingdom

Portfolio

1 total
Triveni Bio

Co-Investors

7
Ascenta Capital · 1 sharedAtlas Venture · 1 sharedCormorant Asset Management · 1 sharedDeep Track Capital · 1 sharedFidelity Investments · 1 sharedOrbiMed Advisors · 1 sharedViking Global Investors · 1 shared

Latest Pulse

  1. Triveni Bio Raises $65M for Antibody Therapeutics in ImmunologyTriveni Bio raised $65 million, co-led by Ascenta Capital and Janus Henderson Investors, to advance antibody-based therapeutics for immunological and inflammatory diseases. The round is a reminder that biotech capital is still flowing to differentiated science even in an AI-dominated market.→
  2. Triveni Bio Raises $65M for Antibody-Based Immunology TherapeuticsTriveni Bio raised $65 million co-led by Ascenta Capital and Janus Henderson to advance antibody-based therapeutics targeting immunological diseases. The round is part of a biotech rebound that's running alongside the AI-infrastructure boom rather than being crowded out by it.→

Suggest a correction